Literature DB >> 12193695

Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion.

Daniele D'Ambrosio1, Cristina Albanesi, Rosmarie Lang, Giampiero Girolomoni, Francesco Sinigaglia, Carlo Laudanna.   

Abstract

Chemokines control the specificity of lymphocyte homing. Numerous chemokines have been identified but the significance of redundancy in chemokine networks is unexplained. Here we investigated the biological significance of distinct chemokines binding to the same receptor. Among CCR4 ligands, skin vessels endothelial cells present C-C chemokine ligand (CCL) 17 but not CCL22 consistent with CCL17 involvement in T lymphocyte arrest on endothelial cells. However, CCL22 is much more powerful than CCL17 in the induction of rapid integrin-dependent T cell adhesion on VCAM-1 under conditions of physiological flow. The dominance of CCL22 over CCL17 extends to other CCR4-mediated phenomena such as receptor desensitization and internalization and correlates with the peculiar kinetics of CCR4 engagement by the two ligands. A similar phenomenological pattern is also shown for CXC chemokine ligand 9 and CXC chemokine ligand 11, which share binding to CXCR3. Our analysis shows how quantitative variations in chemokine receptor expression level and ligand engagement may alter the selectivity of integrin-dependent lymphocyte adhesive responses, suggesting a mechanism by which chemokine networks may either generate or break the specificity of lymphocyte subset recruitment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193695     DOI: 10.4049/jimmunol.169.5.2303

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice.

Authors:  Christian Weber; Svenja Meiler; Yvonne Döring; Miriam Koch; Maik Drechsler; Remco T A Megens; Zuzanna Rowinska; Kiril Bidzhekov; Caroline Fecher; Eliana Ribechini; Marc A M J van Zandvoort; Christoph J Binder; Ivett Jelinek; Mihail Hristov; Louis Boon; Steffen Jung; Thomas Korn; Manfred B Lutz; Irmgard Förster; Martin Zenke; Thomas Hieronymus; Tobias Junt; Alma Zernecke
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  An integrated stochastic model of "inside-out" integrin activation and selective T-lymphocyte recruitment.

Authors:  Michael T Beste; Dooyoung Lee; Michael R King; Gary A Koretzky; Daniel A Hammer
Journal:  Langmuir       Date:  2012-01-04       Impact factor: 3.882

3.  Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module.

Authors:  Matteo Bolomini-Vittori; Alessio Montresor; Cinzia Giagulli; Donald Staunton; Barbara Rossi; Marianna Martinello; Gabriela Constantin; Carlo Laudanna
Journal:  Nat Immunol       Date:  2009-01-11       Impact factor: 25.606

4.  CXCR3 regulates CD4+ T cell cardiotropism in pressure overload-induced cardiac dysfunction.

Authors:  Njabulo Ngwenyama; Ane M Salvador; Francisco Velázquez; Tania Nevers; Alexander Levy; Mark Aronovitz; Andrew D Luster; Gordon S Huggins; Pilar Alcaide
Journal:  JCI Insight       Date:  2019-04-04

Review 5.  Key mechanisms involved in ionizing radiation-induced systemic effects. A current review.

Authors:  Ifigeneia V Mavragani; Danae A Laskaratou; Benjamin Frey; Serge M Candéias; Udo S Gaipl; Katalin Lumniczky; Alexandros G Georgakilas
Journal:  Toxicol Res (Camb)       Date:  2015-08-11       Impact factor: 3.524

Review 6.  Leukocyte arrest: Biomechanics and molecular mechanisms of β2 integrin activation.

Authors:  Zhichao Fan; Klaus Ley
Journal:  Biorheology       Date:  2015       Impact factor: 1.875

7.  CXCL10 stabilizes T cell-brain endothelial cell adhesion leading to the induction of cerebral malaria.

Authors:  Elizabeth W Sorensen; Jeffrey Lian; Aleksandra J Ozga; Yoshishige Miyabe; Sophina W Ji; Shannon K Bromley; Thorsten R Mempel; Andrew D Luster
Journal:  JCI Insight       Date:  2018-04-19

8.  In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.

Authors:  Jagadeesh Bayry; Elma Z Tchilian; Matthew N Davies; Emily K Forbes; Simon J Draper; Srini V Kaveri; Adrian V S Hill; Michel D Kazatchkine; Peter C L Beverley; Darren R Flower; David F Tough
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-11       Impact factor: 11.205

9.  CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow.

Authors:  Stuart M Curbishley; Bertus Eksteen; Ron P Gladue; Patricia Lalor; David H Adams
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

Review 10.  What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?

Authors:  Julien Catherine; Florence Roufosse
Journal:  Semin Immunopathol       Date:  2021-05-19       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.